Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102333 | 0.79 | KDM4E (0.33) | KDM4ESMN1; SMN2 | |
| SCHEMBL20102334 | 0.66 | — | — | |
| SCHEMBL16727947 | 0.59 | BRD4 (0.42) | SMN1; SMN2BRD4 | |
| SCHEMBL11740900 | 0.58 | L3MBTL1 (0.65) | KDM4ESMN1; SMN2 | |
| SCHEMBL18114790 | 0.57 | NR1H2 (0.33) | KDM4ESMN1; SMN2 | |
| SCHEMBL24703554 | 0.57 | KDM4E (0.57) | KDM4ESMN1; SMN2 | |
| SCHEMBL20102335 | 0.57 | — | — | |
| SCHEMBL14123262 | 0.54 | KDM4E (0.49) | KDM4ESMN1; SMN2 | |
| SCHEMBL19010647 | 0.53 | TSHR (0.39) | KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL7340852 | 0.53 | KDM4E (0.52) | KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118765-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS (FR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118765-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | NQO1, PEPD, LCT | KDM4E 3033/4885SMN1; SMN2 3965/4885BRD4 575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.